Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

123.80 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,180
Open 123.80
Bid (Size) 124.50 (15)
Ask (Size) 124.80 (1)
Prev. Close 123.80
Today's Range 123.80 - 123.80
52wk Range 99.14 - 134.63
Shares Outstanding 2,531,374,696
Dividend Yield 2.36%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30
From Merck & Co., Inc.
Via Business Wire
3 Sectors That Could Get Slammed by Attempts to Reduce U.S. Debt
With Washington likely having to take steps to cut the U.S. deficit within the next few years, here are three sectors at risk. 
Via InvestorPlace

Performance

YTD
+9.33%
+9.33%
1 Month
-1.39%
-1.39%
3 Month
-5.49%
-5.49%
6 Month
+9.33%
+9.33%
1 Year
+8.28%
+8.28%

More News

Read More
7 Quiet Blue-Chip Stocks on the Verge of a Big Breakout Rally
Via InvestorPlace
What's Going On With Merck Stock On Friday?
Via Benzinga
A Closer Look at Merck & Co's Options Market Dynamics
Via Benzinga
Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH)
From Merck & Co., Inc
Via Business Wire
CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults
From Merck & Co., Inc.
Via Business Wire
Dow Jones Powerhouse Merck Dives On Surprise FDA Rejection
Via Investor's Business Daily
Topics Stocks
Exposures Product Safety US Equities
This Recent FDA Approval Is Bad News for Pfizer
Via The Motley Fool
Exposures Product Safety
FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug
Via Benzinga
Exposures Product Safety
These Are The Best Dow Jones Stocks Of 2024 Thus Far
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer
From Daiichi Sankyo
Via Business Wire
Beating Cancer Is Still An Everything-But-Easy Challenge That Pharmaceutical Companies Cannot Solve Overnight
Via Benzinga
7 Dividend Stocks to Buy Now for Enhanced Returns
Via InvestorPlace
USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
From Merck & Co., Inc.
Via Business Wire
Analyst Sees Keros Therapeutics As Next Acceleron, Set For Major Biotech Growth
Via Benzinga
Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Forget Nvidia: Prominent Billionaires Are Selling It in Favor of These 7 Top-Notch Stocks
Via The Motley Fool
3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains
Via InvestorPlace
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
Via Benzinga
AbbVie Inc. Dividend Stock Analysis - Saturday, June 22
Via Talk Markets
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
Via Benzinga
3 Top Penny Stocks to Skyrocket Your Wealth in 2024
Via InvestorPlace
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
Via FinancialNewsMedia
Topics Death
Exposures Death
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.